Showing results (71-80 of 196) with videos related to
Sort By:
Pageof 20
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidationGiovanni Davì, Matteo Neri, Angela Falco, et al.Circulation|June 18, 2003
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease durationGiovanni Davì, Francesco Chiarelli, Francesca Santilli, et al.JAMA|October 26, 2002
Platelet activation in obese women: role of inflammation and oxidant stressGiovanni Davì, Maria Teresa Guagnano, Giovanni Ciabattoni, et al.Journal of the American Society of Nephrology : JASN|July 23, 2003
Cholesterol and the risk of renal dysfunction in apparently healthy menElke S Schaeffner, Tobias Kurth, Gary C Curhan, et al.International Journal of Obesity (2005)|July 18, 2020
Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK BiobankPengfei Zhu, Sarah Lewington, Richard Haynes, et al.The Journal of Pharmacology and Experimental Therapeutics|November 10, 2010
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptorsGiovanna Petrucci, Raimondo De Cristofaro, Sergio Rutella, et al.Thrombosis and Haemostasis|July 12, 2012
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphismAlfredo Dragani, Angela Falco, Francesca Santilli, et al.Journal of the American College of Cardiology|December 19, 2006
Insulin resistance as a determinant of platelet activation in obese womenStefania Basili, Giovanni Pacini, Maria Teresa Guagnano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2005
Vascular and neoplastic risk in a large cohort of patients with polycythemia veraRoberto Marchioli, Guido Finazzi, Raffaele Landolfi, et al.Kidney International|April 22, 2019
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.Pageof 20